On the Nature and Ethics of Phase I Clinical Trials of Cancer Chemotherapies
The DOI matches its Crossref record.
Abstract
PHYSICIANS and members of the public understand that each new drug must, at some point, be given to humans for the first time without confident knowledge of its effects and toxic potential. Although the ethics and constraints necessary for this testing have been discussed widely, there has been little attention given specifically to the first trials of new cancer chemotherapeutic agents (phase I trials). However, new cancer chemotherapeutic agents cannot be treated simply as new drugs; their toxic effects are often so much greater than those of other drugs that the clinical investigator must weigh many conflicting arguments to justify the trial. Referring physicians, in their role as advisors, are often called on to explain the trials and to counsel patients who may enter them. Thus, they should have full appreciation of the nature and ethics of such trials. A phase I clinical trial in patients with cancer does not
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
What Makes Clinical Research Ethical?
Emanuel, E. J. (2000) · JAMA · doi:10.1001/jama.283.20.2701 · Cited by 2,710
Perceptions of cancer patients and their physicians involved in phase I trials.
Daugherty, C., Ratain, M. J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., & Siegler, M. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1062 · Cited by 515
Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002
Horstmann, E., McCabe, M. S., Grochow, L., Yamamoto, S., Rubinstein, L., Budd, T., Shoemaker, D., Emanuel, E. J., & Grady, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa042220 · Cited by 441
Quality of Informed Consent: a New Measure of Understanding Among Research Subjects
Joffe, S., Cook, E. F., Cleary, P. D., Clark, J. W., & Weeks, J. C. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.2.139 · Cited by 408
Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
Roberts, T. G. (2004) · JAMA · doi:10.1001/jama.292.17.2130 · Cited by 319
Metadata
- Authors
- Lipsett, M. B.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1982-08-27
- Volume
- 248
- Issue
- 8
- Pages
- 941
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2020352568
- Cited by
- 81
- References
- 0
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: On the Nature and Ethics of Phase I Clinical Trials of Cancer Chemotherapies. https://app.cochat.ai/papers/10.1001/jama.1982.03330080023022
- The paper
- Lipsett, M. B. (1982). On the Nature and Ethics of Phase I Clinical Trials of Cancer Chemotherapies. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1982.03330080023022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.